1 Stock That Is Not Worth Chasing in 2022

: BYND | Beyond Meat Inc. News, Ratings, and Charts

BYND – As demand for vegan alternatives for meat-based products grows, Beyond Meat’s (BYND) innovative business model has enabled them to grab the market. However, the company’s lack of profitability and lofty valuation has raised significant investor concerns over its prospects. In addition, poor analysts’ ratings further make the stock’s near-term prospects look gloomy. So, we think the stock is best avoided now. Read on…

Beyond Meat, Inc. (BYND) is a leading plant-based protein firm that provides a portfolio of revolutionary plant-based proteins created from basic ingredients that do not include GMOs, bioengineered chemicals, hormones, antibiotics, or cholesterol. The company’s shares have surged 46.2% over the past month.

However, the stock has declined 72.2% over the past year and 46.8% year-to-date to close its last trading session at $34.68. In addition, the stock is currently trading below its 52-week high of $134.99, which it hit on August 10, 2021.

According to Piper Sandler analyst Michael Lavery, Beyond Meat retail sales growth is continuing to drop, and the new jerky’s early success is “masking a greater acceleration in declines for the rest of its portfolio.”

In addition, last month, BTIG analyst Peter Saleh warned clients about BYND’s association with McDonald’s Corporation (MCD). BYND is a partner in McDonald’s McPlant burger, which, according to Saleh, is not doing well. As a result, the analyst doubts that McPlant will be on McDonald’s national U.S. menu later this year.

Here’s what could shape BYND’s performance in the near term:

Premium Valuation

In terms of forward EV/Sales, the stock is currently trading at 4.96x, 176.5% higher than the industry average of 1.80x. Also, its forward Price/Sales of 3.89x is 229.9% higher than the industry average of 1.18x. Moreover, BYND’s trailing-12-month Price/Book of 53.76x is 1996.6% higher than the industry average of 2.56x.

Inadequate Financials

BYND’s revenue increased 1.19% year-over-year to $109.46 million for the first quarter ended April 02, 2022. Its operating loss grew 296.1% from the year-ago value to $97.62 million. The company’s net loss surged 268.4% from the prior-year quarter to $100.46 million. In addition, its net cash used in operating activities came in at $165.21 million, representing a year-over-year increase of 438.9%.

Negative Profit Margins

BYND’s trailing-12-month gross profit margin of 18.2% is 44.1% lower than the industry average of 32.5%. Also, its trailing-12-month ROA, ROC, and net income margin are negative 19.7%, 11.1%, and 54.8%, respectively. Moreover, its trailing-12-month negative EBITDA margin of 44.5% compares to its industry average of 12.1%.

Consensus Rating and Price Target Indicate Potential Downside

Of the 11 Wall Street analysts that rated BYND, four rated it Sell, and seven rated it Hold. The 12-month median price target of $24.38 indicates a 29.7% potential downside. The price targets range from a low of $14.00 to a high of $44.00.

POWR Ratings Reflect Bleak Outlook

BYND has an overall F rating, which equates to a Strong Sell in our proprietary POWR Ratings system. The POWR ratings are calculated considering 118 different factors, with each factor weighted to an optimal degree.

Our proprietary rating system also evaluates each stock based on eight different categories. BYND has an F for Stability and Sentiment. The stock beta of 1.65 is consistent with the Stability grade. In addition, consensus rating and price targets are in sync with the Sentiment grade.

Of the 86 stocks in the B-rated Food Makers industry, BYND is ranked last.

Beyond what I’ve stated above, you can view BYND ratings for Value, Growth, Momentum, and Quality here.

Bottom Line

BYND’s widening losses and poor consensus price estimates are concerning. Furthermore, analysts expect its EPS to decline by 277.4% in the current quarter ended June 2022 and 55.7% in the current fiscal year. So, we think the stock is best avoided now.

How Does Beyond Meat Inc. (BYND) Stack Up Against its Peers?

While BYND has an overall F rating, one might want to consider its industry peers, Industrias Bachoco S.A.B. de C.V. (IBA), JBS S.A. (JBSAY), and Sanderson Farms Inc. (SAFM), which have an overall A (Strong Buy) rating.

BYND shares rose $0.77 (+2.22%) in premarket trading Tuesday. Year-to-date, BYND has declined -46.78%, versus a -18.98% rise in the benchmark S&P 500 index during the same period.

About the Author: Pragya Pandey

Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
BYNDGet RatingGet RatingGet Rating
IBAGet RatingGet RatingGet Rating
JBSAYGet RatingGet RatingGet Rating
SAFMGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com

Will Stocks Continue to Rise...Or Time for Rug Pull?

It’s hard not to celebrate each new high for the S&P 500 (SPY). Yet with high inflation not dead and buried then perhaps this stock market celebration is a tad early. That is why you need to hear what 44 year investment veteran Steve Reitmeister is saying about what comes next for the stock market and how to stay on the right side of the action. Read on below for more...

4 Software Stocks Primed for Major Upside in 2024

The software industry is thriving, buoyed by digital transformation, soaring demand for cloud solutions, and the integration of advanced technologies like AI and ML, presenting lucrative opportunities for savvy investors. So, let’s look at tech stocks SS&C Technologies (SSNC), Informatica (INFA), Verint Systems (VRNT), and Yext (YEXT) poised for significant upside in 2024. Read on…

3 Pharma Stocks Primed for May Investment Opportunities

The pharma industry is poised for tremendous growth driven by surging healthcare needs, the introduction of groundbreaking medications, and relentless technological innovation. Hence, quality pharma stocks Collegium Pharmaceutical (COLL), Green Thumb Industries (GTBIF), and Bristol-Myers Squibb (BMY) emerge as prime investment options this month. Read more…

3 Bargain Internet Stock Buys for Savvy Investors

The increased internet penetration is reshaping various industries, driving digital transformation, connectivity, and access to services like e-commerce, remote work, and online entertainment. Thus, robust internet stocks Jamf Holding (JAMF), Upwork (UPWK), and TrueCar (TRUE), which are trading at discounts to their peers, could be ideal buys. Keep reading…

2 Paths for Stocks from Here

The recent rally for the S&P 500 (SPY) is nice to see. However, it is quite possible this is the end of the line for recent stock gains with more downside ahead. To explain the 2 distinct possibilities for stocks at this time is 44 year investment veteran Steve Reitmeister who shares this updated marketing outlook with trading plan and top picks in the article below...

Read More Stories

More Beyond Meat Inc. (BYND) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All BYND News